Westport Fuel Systems Signs US$20 Million Loan Agreement from Export Development Canada
Dec 21, 2017 13:01 pm UTC| Business
VANCOUVER, British Columbia, Dec. 21, 2017 -- Westport Fuel Systems Inc. (“Westport Fuel Systems”) (TSX:WPRT) (Nasdaq:WPRT) and Export Development Canada (“EDC”) announced today that they have signed a US$20 million...
Optium Cyber Systems Signs Revenue Contract
Dec 21, 2017 13:01 pm UTC| Business
THE WOODLANDS, TEXAS, Dec. 21, 2017 -- Optium Cyber Systems, Inc. (the Company) (OTC:OCSY) is pleased to announce the signing of a one year consulting and services agreement worth over $280,000. The contract was...
Dec 21, 2017 13:01 pm UTC| Business
MIAMI, FL, Dec. 21, 2017 -- Amazon Hemp Ltd. (www.azhempusa.com) a wholly owned subsidiary of Amazonas Florestal Ltd. (www.azflusa.com) (OTC: PINK: AZFL), a natural resources company dedicated to innovative, sustainable...
Dec 21, 2017 13:01 pm UTC| Business
VANCOUVER, British Columbia, Dec. 21, 2017 -- Graphite One Resources Inc. (TSX-V:GPH) (OTCQB:GPHOF) (“Graphite One” or the “Company”) commented today on the release of the US Geological Survey’s report on the Critical...
CRISPR Therapeutics Announces Appointment of Dr. Rodger Novak as Chairman of the Board
Dec 21, 2017 13:01 pm UTC| Business
ZUG, Switzerland and CAMBRIDGE, Mass., Dec. 21, 2017 -- CRISPR Therapeutics (NASDAQ:CRSP) today announced the appointment of Dr. Rodger Novak, founder and former CEO of CRISPR Therapeutics as Chairman of the Board of...
Gopher Initiates Prototype Development of the GUARDIAN ORB Proprietary Pet Tracking Product
Dec 21, 2017 13:01 pm UTC| Business
SAN DIEGO, CA, Dec. 21, 2017 -- Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher" and the "Company"), a development-stage company which specializes in the creation of Internet of Things (IoT) and Artificial Intelligence...
aTyr Pharma Announces Poster Presentation at ASCO-SITC Clinical Immuno-Oncology Symposium
Dec 21, 2017 13:01 pm UTC| Business
SAN DIEGO, Dec. 21, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of immuno-modulatory protein therapeutics to treat patients suffering from rare, severe,...